Emerging Company Profile
PAQ: small molecules for autophagy-dependent degradation
Emerging Company Profile: PAQ is creating small molecules that promote autophagy-dependent degradation of proteins and non-proteins
PAQ Therapeutics is creating autophagosome-tethering compounds for targeted degradation of proteins and non-proteins via the autophagy pathway.
Jul 22, 2021 | 8:34 PM GMT
With a July 15th $30 million series A round